Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAN-ZOSTER
NCT07485283Phase 4Active, not recruiting
- Start
- Apr 2026
- Primary completion
- Jun 2029
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in cardiovascular disease (CVD), Dementia. Started Apr 2026; status: active, not recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
cardiovascular disease (CVD)Dementia
Beyond the preview
Go deeper on NCT07485283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485283.